blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3303579

EP3303579 - ASSAYS TO IDENTIFY GENETIC ELEMENTS AFFECTING PHENOTYPE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.02.2022
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  05.03.2021
FormerGrant of patent is intended
Status updated on  09.12.2020
FormerExamination is in progress
Status updated on  18.09.2020
FormerGrant of patent is intended
Status updated on  24.06.2020
FormerExamination is in progress
Status updated on  25.03.2019
FormerRequest for examination was made
Status updated on  09.03.2018
FormerThe international publication has been made
Status updated on  02.12.2016
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis
Plesmanlaan 121
1066 CX Amsterdam / NL
[2021/14]
Former [2018/15]For all designated states
Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis
Plesmanlaan 121
1066 CX Amsterdam / NL
Inventor(s)01 / BRUMMELKAMP, Thijn Reinout
c/o 121 Plesmanlaan
1066 CX Amsterdam / NL
02 / NIEUWENHUIS, Joppe Daniël Maria
c/o 121 Plesmanlaan
1066 CX Amsterdam / NL
03 / JAE, Lucas Tilmann
c/o 121 Plesmanlaan
1066 CX Amsterdam / NL
04 / BROCKMANN, Markus
c/o 121 Plesmanlaan
1066 CX Amsterdam / NL
05 / BLOMEN, Vincent Arthur
c/o 121 Plesmanlaan
1066 CX Amsterdam / NL
06 / RAABEN, Matthijs
c/o 121 Plesmanlaan
1066 CX Amsterdam / NL
 [2021/14]
Former [2018/15]01 / BRUMMELKAMP, Thijn Reinout
c/o 121
Plesmanlaan
1066 CX Amsterdam / NL
02 / NIEUWENHUIS, Joppe Daniël Maria
c/o 121
Plesmanlaan
1066 CX Amsterdam / NL
03 / JAE, Lucas Tilmann
c/o 121
Plesmanlaan
1066 CX Amsterdam / NL
04 / BROCKMANN, Markus
c/o 121
Plesmanlaan
1066 CX Amsterdam / NL
05 / BLOMEN, Vincent Arthur
c/o 121
Plesmanlaan
1066 CX Amsterdam / NL
06 / RAABEN, Matthijs
c/o 121
Plesmanlaan
1066 CX Amsterdam / NL
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2021/14]
Former [2018/15]Algemeen Octrooi- en Merkenbureau B.V.
P.O. Box 645
5600 AP Eindhoven / NL
Application number, filing date16744892.727.05.2016
[2018/15]
WO2016NL50381
Priority number, dateNL2015201487728.05.2015         Original published format: NL 2014877
[2018/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016190743
Date:01.12.2016
Language:EN
[2016/48]
Type: A1 Application with search report 
No.:EP3303579
Date:11.04.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 01.12.2016 takes the place of the publication of the European patent application.
[2018/15]
Type: B1 Patent specification 
No.:EP3303579
Date:07.04.2021
Language:EN
[2021/14]
Search report(s)International search report - published on:EP01.12.2016
ClassificationIPC:C12N15/01, C12N15/10
[2018/15]
CPC:
C12N15/01 (EP,US); C12N15/1051 (US); C12N15/1024 (EP,US);
C12N15/1079 (EP,US); C12Q1/6809 (EP); C12Q1/6886 (EP,US);
G01N33/502 (EP); G01N33/574 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/15]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:TESTS ZUR IDENTIFIZIERUNG GENETISCHER, DEN PHÄNOTYP BEEINFLUSSENDER ELEMENTE[2018/15]
English:ASSAYS TO IDENTIFY GENETIC ELEMENTS AFFECTING PHENOTYPE[2018/15]
French:ANALYSES PERMETTANT D'IDENTIFIER DES ÉLÉMENTS GÉNÉTIQUES AFFECTANT LE PHÉNOTYPE[2018/15]
Entry into regional phase22.12.2017National basic fee paid 
22.12.2017Designation fee(s) paid 
22.12.2017Examination fee paid 
Examination procedure22.12.2017Examination requested  [2018/15]
22.12.2017Date on which the examining division has become responsible
23.07.2018Amendment by applicant (claims and/or description)
28.03.2019Despatch of a communication from the examining division (Time limit: M04)
07.08.2019Reply to a communication from the examining division
25.06.2020Communication of intention to grant the patent
17.09.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
10.12.2020Communication of intention to grant the patent
19.02.2021Fee for grant paid
19.02.2021Fee for publishing/printing paid
19.02.2021Receipt of the translation of the claim(s)
Divisional application(s)EP21167038.5  / EP3892724
Opposition(s)10.01.2022No opposition filed within time limit [2022/11]
Fees paidRenewal fee
25.05.2018Renewal fee patent year 03
23.05.2019Renewal fee patent year 04
19.03.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.05.2016
AL07.04.2021
CY07.04.2021
CZ07.04.2021
EE07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
MK07.04.2021
MT07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
TR07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
[2024/42]
Former [2024/29]HU27.05.2016
AL07.04.2021
CY07.04.2021
CZ07.04.2021
EE07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
MK07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
TR07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2024/22]HU27.05.2016
AL07.04.2021
CY07.04.2021
CZ07.04.2021
EE07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
MK07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2023/30]HU27.05.2016
AL07.04.2021
CY07.04.2021
CZ07.04.2021
EE07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2023/29]HU27.05.2016
AL07.04.2021
CZ07.04.2021
EE07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/29]AL07.04.2021
CZ07.04.2021
EE07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SI07.04.2021
SK07.04.2021
SM07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/26]AL07.04.2021
CZ07.04.2021
EE07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SK07.04.2021
SM07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/23]CZ07.04.2021
EE07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SK07.04.2021
SM07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/10]CZ07.04.2021
EE07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SK07.04.2021
SM07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
PT09.08.2021
IS22.12.2021
Former [2022/09]CZ07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
PL07.04.2021
RO07.04.2021
RS07.04.2021
SK07.04.2021
SM07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/08]CZ07.04.2021
HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
PL07.04.2021
RS07.04.2021
SM07.04.2021
LU27.05.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2022/07]HR07.04.2021
LT07.04.2021
LV07.04.2021
MC07.04.2021
PL07.04.2021
RS07.04.2021
SM07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2021/52]HR07.04.2021
LT07.04.2021
LV07.04.2021
PL07.04.2021
RS07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2021/51]HR07.04.2021
LT07.04.2021
LV07.04.2021
RS07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
IS07.08.2021
PT09.08.2021
Former [2021/50]HR07.04.2021
LT07.04.2021
LV07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
PT09.08.2021
Former [2021/49]HR07.04.2021
LT07.04.2021
LV07.04.2021
BG07.07.2021
NO07.07.2021
GR08.07.2021
Former [2021/47]LT07.04.2021
BG07.07.2021
Former [2021/46]LT07.04.2021
Cited inInternational search[A]WO2011006145  (WHITEHEAD BIOMEDICAL INST [US], et al) [A] 1-19 * paragraph [0151] - paragraph [0187] *;
 [A]  - ZDENEK ANDRYSIK ET AL, "A Genetic Screen Identifies TCF3/E2A and TRIAP1 as Pathway-Specific Regulators of the Cellular Response to p53 Activation", CELL REPORTS, US, (20130501), vol. 3, no. 5, doi:10.1016/j.celrep.2013.04.014, ISSN 2211-1247, pages 1346 - 1354, XP055249775 [A] 1-19 * Supplemental information ; Results;; figure 1 *

DOI:   http://dx.doi.org/10.1016/j.celrep.2013.04.014
 [T]  - BENJAMIN G GOWEN ET AL, "A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells", ELIFE, (20151113), vol. 26, doi:10.1016/j.ccr.2014.07.010, page 374, XP055249748 [T] * the whole document *

DOI:   http://dx.doi.org/10.7554/eLife.08474
by applicantWO2010094040
 EP2451982
    - SMITH ET AL., ANAL BIOCHEM., (1987), vol. 160, no. 1, pages 135 - 8
    - JAMUR, METHODS MOL BIOL., (2010), vol. 588, pages 63 - 6
    - JOURNAL OF NUCLEIC ACIDS, (2011), vol. 2011
    - KLEMM ET AL., NAT METHODS, (201405), vol. 11, no. 5, pages 549 - 51
    - IBRAHIM SF, ADV BIOCHEM ENG BIOTECHNOL., (2007), vol. 106, pages 19 - 39
    - AUTEBERT J. METHODS, (2012), vol. 57, no. 3, pages 297 - 307
    - "Developmental methods of fixation", J HISTOTECHNOL, (2001), vol. 24, pages 201 - 210
    - SCHMIDT ET AL., NATURE METHODS, (2007), vol. 4, pages 1051 - 7
    - HORN, C ET AL., NAT. GENET., (2007), vol. 39, pages 807 - 8
    - NATURE METHODS, (2005), vol. 2, no. 8
    - VAN OPIJNEN ET AL., NATURE METHODS, (2009), vol. 6, pages 767 - 772
    - SUN ET AL., CELL REPORTS, vol. 7, (2014), pages 86 - 93, URL: http://dx.doi.org/10.1016/j.celrep.2014.02.045
    - DAL SIN, P. ET AL., J PATHOL., (1988), vol. 185, no. 1, pages 112 - 5
    - CARETTE ET AL., NATURE, (2011), vol. 477, no. 7364, pages 340 - 3
    - JAE ET AL., SCIENCE, (2013), vol. 340, no. 6131, pages 479 - 83
    - CARETTE ET AL., SCIENCE, (2009), vol. 326, no. 5957, pages 1231 - 1235
    - BLONDAL ET AL., NUCLEIC ACID RESEARCH, (2005), vol. 33, no. 1, pages 135 - 142
    - LANGMEAD ET AL., GENOME BIOL, (2009), vol. 10, page R25
    - QUINLAN; HALL, BIOINFORMATICS, (2010), vol. 26, no. 6, pages 841 - 842
    - SHALEM ET AL., SCIENCE, (2014), vol. 343, no. 6166, pages 84 - 87
    - MARESCA ET AL., GENOME RES., (201303), vol. 23, no. 3, pages 539 - 46
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.